Harbour Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Harbour Investments’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-98	Closed	-$3.79K	–	3598
2024 Q4	$3.79K	Hold	98	–	–	﹤0.01%	2833
2024 Q3	$4.39K	Hold	98	–	–	﹤0.01%	2669
2024 Q2	$4.07K	Hold	98	–	–	﹤0.01%	2583
2024 Q1	$4.44K	Hold	98	–	–	﹤0.01%	2537
2023 Q4	$4.51K	Sell	98 -17	-15%	-$693	﹤0.01%	2446
2023 Q3	$4.68K	Sell	115 -82	-42%	-$3.73K	﹤0.01%	2298
2023 Q2	$9.57K	Hold	197	–	–	﹤0.01%	2048
2023 Q1	$9.72K	Hold	197	–	–	﹤0.01%	2022
2022 Q4	$9.99K	Sell	197 -125	-39%	-$6.45K	﹤0.01%	1951
2022 Q3	$16K	Hold	322	–	–	﹤0.01%	1744
2022 Q2	$16K	Buy	+322	New	+$16.3K	﹤0.01%	1744
2021 Q4	$70K	Sell	885 -7	-0.8%	-$588	﹤0.01%	1110
2021 Q3	$79K	Hold	892	–	–	﹤0.01%	1507
2021 Q2	$89K	Buy	892 +689	+339%	+$61.1K	﹤0.01%	1465
2021 Q1	$18K	Buy	+203	New	+$20K	﹤0.01%	2270

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Harbour Investments's GNOM Position: Q1 2025 in Review

Harbour Investments sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 98 shares — an estimated $3.79K sold.

Harbour Investments first reported a position in GNOM in Q1 2021 and held it in 15 quarters. The position peaked at $89K in Q2 2021. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

Harbour Investments reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Harbour Investments sold 98 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $3.79K.
Harbour Investments first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 15 quarters.
Harbour Investments's Global X Genomics & Biotechnology ETF position peaked at $89K in Q2 2021.
60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Harbour Investments's 13F filing for Q1 2025, filed 8 May 2025.